Literature DB >> 7038044

The conversion of hepatitis B core antigen synthesized in E coli into e antigen.

P MacKay, J Lees, K Murray.   

Abstract

The antigen (HBeAg) of hepatitis B virus (HBV) is a polypeptide of 17-20,000 daltons closely associated with the core antigen (HBcAg) of Dane particles, from which it is released by a variety of disruptive procedures. HBeAg could be a unique component of HBV core particles or a derivative of HBcAg. To resolve this question immunodiffusion experiments were carried out with preparations of HBcAg synthesized in E coli carrying a recombinant plasmid from which the HBcAg, but no other HBV gene, was expressed. HBcAg was converted into HBeAg by proteolytic degradation under dissociating conditions, thus confirming at the molecular level that HBeAg is a component of HBcAg. This offers a new route to the detection of HBeAg and antibodies to the antigen.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7038044     DOI: 10.1002/jmv.1890080404

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  40 in total

1.  Transcriptional trans-activating function of hepatitis B virus.

Authors:  J S Twu; R H Schloemer
Journal:  J Virol       Date:  1987-11       Impact factor: 5.103

Review 2.  Serological responses to HBV infection.

Authors:  E A Fagan; R Williams
Journal:  Gut       Date:  1986-07       Impact factor: 23.059

3.  Hepatitis B virus nucleocapsid assembly: primary structure requirements in the core protein.

Authors:  F Birnbaum; M Nassal
Journal:  J Virol       Date:  1990-07       Impact factor: 5.103

Review 4.  Hepatitis B virus components produced by the human hepatoma cell line PLC/PRF/5: do they indicate virus propagation? Brief review.

Authors:  O Marquardt
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

5.  Hepatitis B core antigen synthesised in Escherichia coli: its use for antibody screening in patients attending a clinic for sexually transmitted diseases.

Authors:  B J Cohen; P A Litton; P P Mortimer; P Simmons
Journal:  J Hyg (Lond)       Date:  1984-10

6.  Expression of hepatitis B antigens with a simian virus 40 vector.

Authors:  H Will; R Cattaneo; E Pfaff; C Kuhn; M Roggendorf; H Schaller
Journal:  J Virol       Date:  1984-05       Impact factor: 5.103

7.  Chimeric hepatitis B virus core particles as probes for studying peptide-integrin interactions.

Authors:  M A Chambers; G Dougan; J Newman; F Brown; J Crowther; A P Mould; M J Humphries; M J Francis; B Clarke; A L Brown; D Rowlands
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

8.  Expression of hepatitis B virus core antigen gene in Saccharomyces cerevisiae: synthesis of two polypeptides translated from different initiation codons.

Authors:  A Miyanohara; T Imamura; M Araki; K Sugawara; N Ohtomo; K Matsubara
Journal:  J Virol       Date:  1986-07       Impact factor: 5.103

9.  Hepatitis B e-antigen titres for evaluating infectivity during hepatitis B virus infection.

Authors:  E G Lindenschmidt; C F Granato; C Salefsky; R Laufs; H Henning
Journal:  Klin Wochenschr       Date:  1984-03-01

10.  Characterization of cell mediated immune responses to the hepatitis B core protein in man.

Authors:  S P Sylvan; U B Hellström; B Flehmig
Journal:  Clin Exp Immunol       Date:  1987-05       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.